Skip to main content

With 8.7% CAGR, Psoriasis Treatment Market Size worth USD 47.24 billion by [2022-2029]

Written by Customer Service on . Posted in Mergers And Acquisitions.

According to Fortune Business Insights, the Psoriasis Treatment Market size is estimated to reach USD 47.25 Billion by 2029, mentions that the market stood at USD 24.33 billion in 2021 and is likely to exhibit a CAGR of 8.7% between 2022 and 2029

Pune, India, Oct. 07, 2022 (GLOBE NEWSWIRE) — The psoriasis treatment market size was USD 24.33 billion in 2021. The market is projected to grow from USD 26.37 billion in 2022 to USD 47.24 billion in 2029 at a CAGR of 8.7% during the 2022-2029 period. This vital information is presented by Fortune Business Insights™, in its report titled, “Psoriasis Treatment Market, 2022-2029.” Factors, such as rising geriatric population, increasing prevalence of plaque psoriasis, and psoriasis arthritis, will increase the footprint of the market during the forecast period. Additionally, increased focus on biologics by prominent players will foster the market growth.

Industry Development

  • October 2021 – Sun Pharmaceutical Industries Ltd. announced the availability of ILUMYA in Canada for the treatment of moderate-to-severe plaque psoriasis to strengthen its presence in Canada.


Request a Sample Copy of the Research Report:

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/psoriasis-treatment-market-100600


Report Scope & Segmentation

Report CoverageDetails
Forecast Period2022 to 2029
Forecast Period 2021 to 2028 CAGR8.7%
2029 Value ProjectionUSD 47.44 Billion
Base Year2021
Market Size in 2022USD 26.37 Billion
Historical Data for2018 to 2020
No. of Pages166
Key PlayersAbbVie Inc. (U.S.), Novartis AG (Switzerland), Johnson & Johnson Services, Inc. (U.S.), Pfizer Inc. (U.S.), LEO Pharma A/S (Denmark), Merck & Co., Inc. (U.S.)
Psoriasis Treatment Market Growth DriversGrowing Prevalence of Psoriasis
The rise in prevalence of psoriasis around the globe has created a huge demand for safe and effective therapies for the treatment.
Biologics or biological therapy is one of the most adopted treatment options.


Drivers & Restraints

Rising Prevalence of Psoriasis & Rocketing Biological Therapy Approvals to Augment Market Growth

Factors such as the increasing occurrence of psoriasis on a global scale and rising demand for safe and effective therapies will boost the psoriasis treatment market growth during the forecast period. Integration of biologicals in the treatment of psoriatic disorders and rising collaborative efforts among the dominant players will increase the footprint of the market. Also, increased focus on developing biologics will fuel the growth of the market.

However, high medications costs will limit the growth of the market during the forecast period to a certain extent.


To get to know more about the short-term and long-term impact of COVID-19 on this market, please visit:

https://www.fortunebusinessinsights.com/industry-reports/psoriasis-treatment-market-100600


COVID-19 Impact

Increasing Demand for Treatment to Boost Sales During Pandemic

The ongoing pandemic resulted in a positive impact on the market for psoriasis treatment due to contributing factors, including higher demand for treatment, increased investments for R&D, and rising revenue among the dominant players. Additionally, few research organizations linked COVID-19 and psoriasis, which triggered growth in the market volume. The rising telemedicine sector played a great role in increasing the footprint of the market during the forecast period.

Psoriasis Treatment Market Segmentations:

SegmentationBy Drug Class

  • TNF Inhibitors
  • Interleukins Inhibitors
  • Others
By Type

  • Plaque Psoriasis
  • Psoriatic Arthritis
  • Others
By Route of Administration

  • Oral
  • Parenteral/Systemic
  • Topical








Segments

Drug Class, Type, Route of Administration, Distribution Channel, and Region are Studied

Based on drug class, the market is divided into TNF inhibitors, interleukin inhibitors, and others.

By type, the market is broken down into plaque psoriasis, psoriatic arthritis, and others.

With respect to route of administration, the market is segmented across oral, parenteral/systemic, and topical.

By distribution channel, the market is fragmented across hospital pharmacies, retail pharmacies, and online pharmacies.

In terms of geography, the market is categorized into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.


Quick Buy Psoriasis Treatment Market

https://www.fortunebusinessinsights.com/checkout-page/100600

Report Coverage

The market report for psoriasis treatment contains a detailed view by pivoting across critical factors such as leading companies and various segments & sub-segments. Additionally, the report also contains the ongoing industry developments and future market trends. Also, the report also provides the factors that are expected to impact the sector in a meaningful way.

Regional Insights

North America to Steer Toward Dominance Due to Rising Awareness Among Consumers 

North America will occupy the largest psoriasis treatment market share during the forecast period due to the rising adoption of biological therapies, increasing investment regarding research & development, and rising consumer awareness among the general population. Additionally, a strong presence of well-built infrastructure and rising investments in long-term and preventive healthcare facilities will boost the market in the region.

Europe will account for a substantial market share in terms of global contribution due to increasing prevalence of psoriasis across European countries.

Asia Pacific will witness considerable market growth due to increasing government initiatives toward raising awareness among the general population.

Competitive Landscape

Diversified Distribution Networks & Collaborative Efforts to Push Prominent Players Towards a Profitable Path

The sector of psoriasis treatment is highly fragmented with players, including Johnson & Johnson Services, Inc., and AbbVie Inc. occupying a major share. These players are attributed to the top position due to their vast distribution networks. Additionally, they are focused on mergers & acquisitions and collaborations with major dermatology and immunology organizations. For example, in July 2020, Johnson & Johnson Services, Inc announced that it received approval from the U.S. FDA for Stelara. Stelara is a product that is used for treating moderate psoriasis in children from ages 6-11. Others are focused on introducing novel biologics products by introducing huge investment opportunities in R&D.

Get your Customized Research Report:

https://www.fortunebusinessinsights.com/enquiry/customization/psoriasis-treatment-market-100600

List of Key Players Present in the Market

  • AbbVie Inc. (U.S.)
  • Novartis AG (Switzerland)
  • Johnson & Johnson Services, Inc. (U.S.)
  • Pfizer Inc. (U.S.)
  • LEO Pharma A/S (Denmark)
  • Merck & Co., Inc. (U.S.)
  • Amgen Inc. (U.S.)
  • Eli Lilly and Company (U.S.)
  • Evelo Biosciences, Inc. (U.S.)
  • UCB S.A. (Belgium)
  • Sun Pharmaceutical Industries Ltd. (India)

Table Of Content

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • Prevalence of Psoriasis and Psoriatic Arthritis for Key Countries/Region
    • Recent Industry Developments Such as Partnerships, Mergers & Acquisitions, New Product Launches Etc.
    • Pipeline Analysis for Key Companies
    • Regulatory Framework by Key Countries
    • Global Reimbursement Scenario
  • Global Psoriasis Treatment Market Analysis, Insights and Forecast, 2016-2027
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Drug Class
      • TNF Inhibitors
      • Interleukins
      • Others
    • Market Analysis, Insights and Forecast – By Type
      • Plaque Psoriasis
      • Psoriatic Arthritis
      • Others
    • Market Analysis, Insights and Forecast – By Route of Administration
      • Oral
      • Parenteral
      • Topical
    • Market Analysis, Insights and Forecast – By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online pharmacies
    • Market Analysis, Insights and Forecast – By Region
      • North America
      • Europe
      • Asia pacific
      • Latin America
      • Middle East & Africa

ToC Continue…!


Have Any Query? Ask Our Experts:

https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/psoriasis-treatment-market-100600


Frequently Asked Questions

How much is the global psoriasis treatment market worth?

According to Fortune Business Insights the global market stood at USD 24.33 billion in 2021 and is projected to reach USD 47.24 billion by 2029.

What are the key factors driving the psoriasis treatment market growth?

The rise in prevalence of the disease around the globe, growing strategic collaborations and mergers among key players, and the demand for safe and effective therapies for treatment are some of the factors expected to drive the market during the forecast period.

About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Address:

Fortune Business Insights Pvt. Ltd.9th Floor, Icon Tower, Baner –

Mahalunge Road, Baner, Pune-411045,

Maharashtra, India.

Phone:

US: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.